Life science companies operate in a heavily regulated environment and the rules of the game are constantly changing. Join members of Pepper’s Health Sciences Department as they discuss the latest in ...
Life sciences venture capitalists are fundraising at their slowest pace since before the Covid-19 pandemic, even though limited partner interest in the biomedical sector remains strong. Venture ...
Vitrafy Life Sciences Ltd (ASX:VFY) released its Q1 FY2026 investor presentation on October 22, 2025, highlighting the successful delivery of its second-generation cryopreservation unit (VCU2) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback